Immunization Update on ACIP Recommendations for Hepatitis B, Pneumococcal, and Zoster Vaccines
Course Number: WC4314-042022 CE for this course has been extended through July 25, 2022. CE Info
Presenter information and topics:
Mark Weng, , MD MSc, Epidemiologist, CDC
Update: Recommendations of the Advisory Committee on Immunization Practices for Universal Hepatitis B Vaccination in Adults aged 19 through 59 years — United States, 2022
Miwako Kobayashi, MD, MPH, Epidemiologist, CDC
Recommendations on Use of New Pneumococcal Conjugate Vaccines for U.S. Adults
Tara C. Anderson, DVM, MPH, PhD, Epidemiologist, CDC
Use of Recombinant Zoster Vaccine (RZV, Shingrix) in Immunocompromised Adults Aged ≥19 Years and Considerations for Use
Section 508 and Accessibility:
Contact NIPinfo@cdc.gov if you need help with accessibility.